DEVELOPMENT OF DOSIMETRIC SUPPORT AND PLANNING OF RADIONUCLIDE THERAPY WITH RADIOPHARMACEUTICAL LABELED 188Re

被引:0
|
作者
Klyopov, A. N. [2 ]
Krylov, V. V. [1 ]
Kurachenko, Y. A. [2 ]
Matusevich, Eu. S. [2 ]
Snigirev, Eu. V. [2 ]
Aleksandrova, O. P. [2 ]
机构
[1] Minist Hlth, Med Radiol Res Ctr, Moscow, Russia
[2] Natl Res Nucl Univ MEPhI, Obninsk Inst Nucl Power Engn, Moscow, Russia
关键词
D O I
暂无
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
4.8
引用
收藏
页码:317 / 317
页数:1
相关论文
共 50 条
  • [41] Radiolabelling of Lipiodol with generator-produced 188Re for hepatic tumor therapy
    Department of Nuclear Medicine, Veterans General Hospital-Taichung, 160, Sec. 3, Taichung Habor Rd, Taichung, Taiwan
    不详
    不详
    不详
    Appl. Radiat. Isot., 3 (267-271):
  • [42] Biokinetic and dosimetric studies of 188Re-hyaluronic acid: a new radiopharmaceutical for treatment of hepatocellular carcinoma
    Melendez-Alafort, Laura
    Nadali, Anna
    Zangoni, Elena
    Banzato, Alessandra
    Rondina, Maria
    Rosato, Antonio
    Mazzi, Ulderico
    NUCLEAR MEDICINE AND BIOLOGY, 2009, 36 (06) : 693 - 701
  • [43] Development, pharmaceutical validation and radioprotection properties of a new concept of 188W/188Re generator
    De Vos, F
    De Decker, M
    Bacher, K
    Lambert, B
    David, B
    Thierens, H
    Slegers, G
    Dierckx, RA
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S386 - S386
  • [44] Development of a thermosensitive hydrogel system for local delivery of 188Re colloid drugs
    Huang, Feng-Yun
    Huang, Ling-Kuen
    Lin, Wan-Yu
    Luo, Tsai-Yueh
    Tsai, Chang-Shu
    Hsieh, Bor-Tsung
    APPLIED RADIATION AND ISOTOPES, 2009, 67 (7-8) : 1405 - 1411
  • [45] 188Re and 68Ga radiolabeled Starch-Based Microparticles as potential theranostic radiopharmaceutical for Hepatocellular Carcinoma
    Verger, Elise
    Drion, Pierre
    Meffre, Genevieve
    Bernard, Claire
    Duwez, Luc
    Lepareur, Nicolas
    Couturier, Olivier
    Hindre, Francois
    Lacoeuille, Franck
    Hustinx, Roland
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [46] Clinical applications of 188Re-labelled radiopharmaceuticals for radionuclide therapy
    Lambert, B
    de Klerk, JMH
    NUCLEAR MEDICINE COMMUNICATIONS, 2006, 27 (03) : 223 - 229
  • [47] Radiotoxicity of h-R3 monoclonal antibody labeled with 188Re administered intracerebrally in rats
    Gonzalez, B
    Casaco, A
    Alvarez, P
    Leon, M
    Arteaga, M
    Leon, A
    Santana, E
    Bada, A
    Figueredo, R
    Hernández, R
    Iznaga-Escobar, N
    González, F
    Perez, R
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2000, 19 (12): : 684 - 692
  • [48] The development of method for preparation of [188Re] human serum albumin microspheres for therapeutic use
    Pijarowska, Justyna
    Jaron, Antoni
    Mikolajczak, Renata
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 : S390 - S390
  • [49] Chelating Systems for 99mTc/188Re in the Development of Radiolabeled Peptide Pharmaceuticals
    Bolzati, Cristina
    Carta, Davide
    Salvarese, Nicola
    Refosco, Fiorenzo
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2012, 12 (05) : 428 - 461
  • [50] Protein Embedded and Intrinsically Radiolabeled [188Re]ReO x Nanoparticles for Concurrent Radiophotothermal Therapy
    Salvanou, E.
    Apostolopoulou, A.
    Xanthopoulos, S.
    Koelewijn, S.
    van Overeem, P.
    Laurent, G.
    Bazzi, R.
    Denat, F.
    Roux, S.
    Bouziotis, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S128 - S128